Related Experiment Video
Updated: Jun 24, 2026

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
Published on: March 28, 2025
Pediatric hemorrhagic cystitis
Daniel B Decker1, Jose A Karam, Duncan T Wilcox
1Children's Medical Center at Dallas, University of Texas Southwestern Medical Center, Department of Urology, 5323 Harry Hines Boulevard, Dallas, TX 75390-9110, USA. ddeck22@gmail.com
Insights
Hemorrhagic cystitis (HC) affects 10-20% of pediatric bone-marrow transplant (BMT) patients. Current prevention and treatment strategies for this challenging condition require further validation and evidence-based guidelines.
Area of Science:
- Urology
- Pediatric Hematology/Oncology
- Infectious Disease
Background:
- Hemorrhagic cystitis (HC) is a significant complication in pediatric bone-marrow transplant (BMT) recipients.
- Understanding the pathophysiology, incidence, and risk factors is crucial for effective management.
Purpose of the Study:
- To review the current literature on hemorrhagic cystitis (HC) in pediatric bone-marrow transplant (BMT) patients.
- To provide urologists with insights into pathophysiology, prevention, and treatment options for HC.
Main Methods:
- A comprehensive literature search of MEDLINE/PubMed was conducted.
- The review focused on pediatric BMT populations, examining HC incidence, pathophysiology, prevention, and treatment.
Main Results:
- HC incidence in pediatric BMT populations is estimated at 10-20%.
- Emerging evidence suggests a link between BK virus and HC, highlighting a multifactorial etiology.
- Current preventive and therapeutic strategies show modest advances but require further validation through prospective studies.
Conclusions:
- Pediatric BMT patients remain susceptible to HC despite advancements.
- There is a lack of evidence-based treatment guidelines for HC, often necessitating prolonged and multimodal interventions.
- Judicious application of aggressive interventions is recommended due to the complexity of HC management.
Purpose:
To review the current literature as it pertains to hemorrhagic cystitis (HC) in the pediatric bone-marrow transplant (BMT) population. By reviewing the pathophysiology of the disease, preventive methods, and therapeutic options, urologists may be better equipped to manage this challenging clinical scenario.
Materials And Methods:
The HC literature was reviewed using a MEDLINE/PubMed literature search, specifically focusing on the pediatric BMT population as it pertains to the incidence, pathophysiology, prevention, and treatment of HC.
Results:
Conservative estimates of HC incidence in recent retrospective studies of pediatric BMT populations still approach 10-20%. Several high-volume pediatric BMT centers have reported contemporary data on their experience with HC providing increased insight into incidence and pathophysiology. Accumulating evidence linking BK virus to HC is a significant development warranting further investigation. Other contributing agents/risk factors need identification in the likely multifactorial etiology of HC. Preventive and therapeutic strategies have made modest advances, but certainly need further validation with prospective randomized studies.
Conclusions:
Pediatric BMT patients are susceptible for HC development despite preventive measures and improved insight into the pathophysiology. Unfortunately, there are no evidence-based treatment guidelines for this difficult clinical issue that frequently requires prolonged care and multiple treatment modalities necessitating judicious patience in the application of more aggressive interventions.
Related Concept Videos
Acute Pyelonephritis I: Introduction
Urologic Endoscopic Procedure: Cystoscopic Examination
Acute Pyelonephritis II: Diagnostic Studies and Management
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Brain Abscess l: Introduction

